USPTO 2015–2025 USPTO PatentsView US Corporation

Globus Medical, Inc.

USPTO PatentsView assignee record - 1,728 granted patents across 60 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Globus ranks #242 of 49,997 tracked US assignees by granted-patent volume, with 1,728 patents across 60 technology areas.

#242
of 49,997 US assignees by volume
Top 1%
by Innovation Score (68.5/100)
16.3
avg claims per patent
+17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R242 · US Corporation #242 · 1,728 grants

GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-LARGE 1.7K grants
  • TOP-DECILE #242/49,997
  • PHOTO-FINISH Merck Patent
  • CPC-WIDE A61B · 60 areas
  • INNOV-STRONG 68.5/100
  • CLAIMS-RICH 16.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +17% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Merck Patent GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Globus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Globus's Innovation Score is 68.5/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Globus's grant cadence moved

Between 2020–2024, Globus Medical, Inc. received 832 grants versus 713 in 2015–2019 (+17% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2024 at 209 grants and bottomed in 2015 at 101. Lead class A61B accounts for 73.6% of the portfolio across 60 subclasses. Volume neighbours: Baker Hughes Holdings LLC (#238) and Xilinx, Inc. (#246).

Globus's three-year grant acceleration

From 2019–2021 to 2022–2024, Globus Medical, Inc. moved from 441 to 527 grants (1.20x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #790. See the growth leaderboard.

Who files at Globus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Globus holds 1,728 patents at rank #242, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Globus

By rank, the assignees closest to #242 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Globus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Globus, neither rank-band nor same-CPC leaders (those blocks stay above).

Globus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

69 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

50100150200250 20152016201720182019202020212022202320242025 183
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Globus Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 101 5.8%
2016 147 8.5%
2017 150 8.7%
2018 179 10.4%
2019 136 7.9%
2020 171 9.9%
2021 134 7.8%
2022 154 8.9%
2023 164 9.5%
2024 209 12.1%
2025partial year 183 10.6%

Which technologies does Globus Medical, Inc. patent most?

Top 15 of 60 technology areas

Where it ranks

Overall rank by patents

#242

of 49,997 tracked assignees

Innovation Score

68.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Globus Medical, Inc.'s patent record in context - here's where to go next.

  • Globus Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 73.6% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #242 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Globus Medical, Inc. against Baker Hughes Holdings LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 68.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.